These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25018787)

  • 1. Roles for the High Affinity IgE Receptor, FcεRI, of Human Basophils in the Pathogenesis and Therapy of Allergic Asthma: Disease Promotion, Protection or Both?
    Youssef LA; Schuyler M; Wilson BS; Oliver JM
    Open Allergy J; 2010; 3():91-101. PubMed ID: 25018787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced FcepsilonRI-mediated release of asthma-promoting cytokines and chemokines from human basophils during omalizumab therapy.
    Oliver JM; Tarleton CA; Gilmartin L; Archibeque T; Qualls CR; Diehl L; Wilson BS; Schuyler M
    Int Arch Allergy Immunol; 2010; 151(4):275-84. PubMed ID: 19844128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
    Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
    Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
    Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
    Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils.
    Kepley CL; Cambier JC; Morel PA; Lujan D; Ortega E; Wilson BS; Oliver JM
    J Allergy Clin Immunol; 2000 Aug; 106(2):337-48. PubMed ID: 10932079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.
    MacGlashan D; Saini S; Schroeder JT
    J Allergy Clin Immunol; 2021 Jun; 147(6):2295-2304.e12. PubMed ID: 33716077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the inflammatory cascade effect of basophil activation in children with allergic rhinitis or asthma, via the IgE-FcεRI-NF-κB signaling pathway.
    Qiao Y; Chen J
    Adv Clin Exp Med; 2021 Jul; 30(7):673-679. PubMed ID: 34118145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease.
    Gomez G
    Front Immunol; 2019; 10():175. PubMed ID: 30792720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.
    Zellweger F; Buschor P; Hobi G; Brigger D; Dahinden CA; Villiger PM; Eggel A
    Cell Death Dis; 2018 May; 9(5):510. PubMed ID: 29724998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine release from the basophils of control and asthmatic subjects and a comparison of gene expression between "releaser" and "nonreleaser" basophils.
    Youssef LA; Schuyler M; Gilmartin L; Pickett G; Bard JD; Tarleton CA; Archibeque T; Qualls C; Wilson BS; Oliver JM
    J Immunol; 2007 Apr; 178(7):4584-94. PubMed ID: 17372017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of the Basophil High-Affinity IgE Receptor in Chronic Urticaria: Clinical Experience from a Tertiary Care Institution.
    Deza G; March-Rodríguez A; Sánchez S; Ribas-Llauradó C; Soto D; Pujol RM; Gimeno R; Giménez-Arnau AM
    J Allergy Clin Immunol Pract; 2019; 7(5):1619-1626.e1. PubMed ID: 30685572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria.
    Vonakis BM; Vasagar K; Gibbons SP; Gober L; Sterba PM; Chang H; Saini SS
    J Allergy Clin Immunol; 2007 Feb; 119(2):441-8. PubMed ID: 17125820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Auto-anti-IgE": naturally occurring IgG anti-IgE antibodies may inhibit allergen-induced basophil activation.
    Chan YC; Ramadani F; Santos AF; Pillai P; Ohm-Laursen L; Harper CE; Fang C; Dodev TS; Wu SY; Ying S; Corrigan CJ; Gould HJ
    J Allergy Clin Immunol; 2014 Dec; 134(6):1394-1401.e4. PubMed ID: 25112697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.
    Oda Y; Fukunaga A; Washio K; Imamura S; Mizuno M; Hatakeyama M; Ogura K; Nishigori C
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1166-1176.e8. PubMed ID: 32898709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basophils from allergic patients are neither hyperresponsive to activation signals nor hyporesponsive to inhibition signals.
    Cassard L; Sperber K; Buivan TP; Cotillard A; Bourdet-Sicard R; Albert ML; Mottez E; Laurent J; Guinnepain MT; Daëron M
    J Allergy Clin Immunol; 2018 Nov; 142(5):1548-1557. PubMed ID: 29366701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen-Specific IgA Antibodies Block IgE-Mediated Activation of Mast Cells and Basophils.
    El Ansari YS; Kanagaratham C; Burton OT; Santos JV; Hollister BA; Lewis OL; Renz H; Oettgen HC
    Front Immunol; 2022; 13():881655. PubMed ID: 35865546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between serum IgE and surface levels of FcepsilonR on human leukocytes in various diseases: correlation of expression with FcepsilonRI on basophils but not on monocytes or eosinophils.
    Saini SS; Klion AD; Holland SM; Hamilton RG; Bochner BS; Macglashan DW
    J Allergy Clin Immunol; 2000 Sep; 106(3):514-20. PubMed ID: 10984372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the use of genetically engineered negative signaling molecules to treat allergic diseases.
    Saxon A; Zhu D; Zhang K; Chan LA; Kepley CL
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):223-31; discussion 231-3. PubMed ID: 17393744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
    Eggel A; Baravalle G; Hobi G; Kim B; Buschor P; Forrer P; Shin JS; Vogel M; Stadler BM; Dahinden CA; Jardetzky TS
    J Allergy Clin Immunol; 2014 Jun; 133(6):1709-19.e8. PubMed ID: 24642143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab may not inhibit mast cell and basophil activation in vitro.
    Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.